(Fixes typo in headline)
June 26 (Reuters) - New York-based hedge fund Paulson & Co on Monday reported a 6.3 percent stake in Canada's Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO , VRX.N .
Paulson, who is Valeant's biggest stakeholder, had a 5.68 percent stake in the company as of March 31, according to Thomson Reuters data. week, billionaire investor John Paulson, joined the ailing drug company's board as it restructures to repay debt.